Note: Artiva Biotherapeutics's revenues are gauged from an analysis of company filings.
Artiva Biotherapeutics's Income Statement (based on Industry Averages)
Artiva Biotherapeutics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Artiva Biotherapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
April 5, 2021
27
100%
$120 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Artiva Biotherapeutics is developing and marketing.
Artiva Biotherapeutics doesn't have any recent trademark applications, indicating Artiva Biotherapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
ALLONK Cells for medical or clinical use; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of breast cancer; Pharmaceutical preparations for the treatment of lymphoma; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer; Therapeutic pharmaceutical for the treatment of breast cancer; Therapeutic pharmaceutical for the treatment of lymphoma; Therapeutic pharmaceutical for the treatment of tumors; Tumor suppressing agents; Anti-cancer preparations; Biological preparations for the treatment of cancer; Biological preparations for the treatment of breast cancer; Biological preparations for the treatment of lymphoma; Biological preparations for the treatment of tumors; Living cells for medical use; Pharmaceutical products for the treatment of cancer
03/04/2021
See all trademarks and details in the Full Report.
Market Share of Artiva Biotherapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Artiva Biotherapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Artiva Biotherapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Artiva Biotherapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.